“Lung cancer survival in Norway, 1997–2011: from nihilism to optimism.” Yngvar Nilssen, Trond Eirik Strand, Lars Fjellbirkeland, Kristian Bartnes and Bjørn Møller. Eur Respir J 2016; 47: 275–287.
Related content which might interest you:
“ERS and tobacco harm reduction.” Charlotta Pisinger, Elif Dagli, Filippos T. Filippidis, Linnea Hedman, Christer Janson, Stelios Loukides, Sofia Ravara, Isabel Saraiva and Jørgen Vestbo, the ERS Tobacco Control Committee, on behalf of the ERS. Eur Respir J 2019; 54: 1902009. Source: Eur Respir J, 55 (1) 1952009; 10.1183/13993003.52009-2019 Year: 2020
“Cladribine improves lung cysts and pulmonary function in a child with histiocytosis.” Ralph Epaud, Hubert Ducou Le Pointe, Sylvie Fasola, Sandra Ploussard, Celine Delestrain, Chiara Sileo and Jean Donadieu. Eur Respir J 2015; 45: 831–833. Source: Eur Respir J 2016; 47: 692 Year: 2016
“Lung function race, ethnicity: a conundrum.” Philip H. Quanjer. Eur Respir J 2013; 41: 1249–1251. Source: Eur Respir J 2013; 42: 1162 Year: 2013
“Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia”. Katherine Floyd, Raymond Hutubessy, Kai Kliiman, Rosella Centis, Nina Khurieva, Wieslaw Jakubowiak, Manfred Danilovits, Genadi Peremitin, Salmaan Keshavjee and Giovanni Battista Migliori. Eur Respir J 2012; 40: 133–142.}, Source: Eur Respir J 2012; 40: 800 Year: 2012
“Towards a total ban on links with the tobacco industry: new rules for the ERS.” Klaus F. Rabe, Christina Gratziou, Brian Ward and Florence Berteletti. Eur Respir J 2012; 40: 809–810. Source: Eur Respir J 2012; 40: 1307 Year: 2012
“RESPIRE: breathing new life into bronchiectasis.” Sanjay H. Chotirmall and James D. Chalmers. Eur Respir J 2018; 51: 1702444. Source: Eur Respir J, 51 (2) 1752444; 10.1183/13993003.52444-2017 Year: 2018
“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057. Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018 Year: 2018
“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051. Source: Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019 Year: 2020
“Exercise pulmonary haemodynamics: a test in search of purpose.” J. Gerry Coghlan and Harm Jan Bogaard. Eur Respir J 2016; 47: 1315–1317. Source: Eur Respir J 2016; 48: 285 Year: 2016
“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784. Source: Eur Respir J 2016; 48: 593 Year: 2016
“Desquamative interstitial pneumonia: a systematic review of its features and outcomes.” Merel E. Hellemons, Catharina C. Moor, Jan von der Thüsen, Mariska Rossius, Arlette Odink, Laila Haugen Thorgersen, Johny Verschakelen, Wim Wuyts, Marlies S. Wijsenbeek and Elisabeth Bendstrup. Eur Respir Rev 2020; 29: 190181. Source: Eur Respir Rev, 29 (157) 190181; 10.1183/16000617.5181-2019 Year: 2020
“Pulmonary arterial hypertension in patients treated with interferon.” Laurent Savale, Caroline Sattler, Sven Günther, David Montani, Marie-Camille Chaumais, Swanny Perrin, Xavier Jaïs, Andrei Seferian, Roland Jovan, Sophie Bulifon, Florence Parent, Gérald Simonneau, Marc Humbert and Olivier Sitbon. Eur Respir J 2014; 44: 1627–1634. Source: Eur Respir J 2015; 46: 1854 Year: 2015
“Alveolar macrophages carbon load: a marker of exposure?” Chinedu Nwokoro, Rossa Brugha and Jonathan Grigg. Eur Respir J 2013; 41: 763. Source: Eur Respir J 2013; 42: 295 Year: 2013
“Asthma inhaler adherence determinants in adults: systematic review of observational data.” Alexandra L. Dima, Gimena Hernandez, Oriol Cunillera, Montserrat Ferrer, Marijn de Bruin and the ASTRO-LAB group. Eur Respir J 2015; 45: 994–1018. Source: Eur Respir J 2016; 47:1892 Year: 2016
“GINA 2015: the latest iteration of a magnificent journey.” Jean Bousquet and Marc Humbert. Eur Respir J 2015; 46: 579–582. Source: Eur Respir J 2015; 46: 1854 Year: 2015
“Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.” Brigitte Benard, Valérie Bastien, Benjamin Vinet, Roger Yang, Maja Krajinovic and Francine M. Ducharme. Eur Respir J 2017; 50: 1700148. Source: Eur Respir J, 50 (5) 1750148; 10.1183/13993003.50148-2017 Year: 2017
“Idiopathic inflammatory myopathies and the lung.” Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216–238. Source: Eur Respir Rev 2015; 24: 545 Year: 2015
“Clean air in Europe: beyond the horizon?” Bert Brunekreef, Nino Künzli, Juha Pekkanen, Isabella Annesi-Maesano, Bertil Forsberg, Torben Sigsgaard, Menno Keuken, Francesco Forastiere, Maeve Barry, Xavier Querol and Roy M. Harrison. Eur Respir J 2015; 45: 7–10. Source: Eur Respir J 2015; 45: 861 Year: 2015
“Umeclidinium in patients with COPD: a randomised, placebo-controlled study.” Roopa Trivedi, Nathalie Richard, Rashmi Mehta and Alison Church. Eur Respir J 2014; 43: 72–81. Source: Eur Respir J 2014; 44: 555 Year: 2014
“Long-term volume-targeted pressure-controlled ventilation: sense or nonsense?” Maria Paola Arellano-Maric, Cesare Gregoretti, Marieke Duiverman and Wolfram Windisch. Eur Respir J 2017; 49: 1602193. Source: Eur Respir J, 50 (1) 1652193; 10.1183/13993003.52193-2016 Year: 2017